1.Investigation and Trend Prediction of Disease Burden of Hypertensionin the Elderly Population Globally and in China from 1990 to 2021
Xiaoxiao ZHAO ; Xiaohui LU ; Lixin KE ; Wulin GAO ; Xiangran MENG ; Lili REN ; Yunhan DING ; Qiang ZHANG ; Yangqin XUN ; Jibiao WU ; Cuncun LU
Medical Journal of Peking Union Medical College Hospital 2025;16(3):647-658
To analyze the disease burden of hypertension in the elderly population from 1990 to 2021 and to predict future trends in China and globally, thereby providing insights for public health decision-making regarding older adults with hypertension in China. Data on hypertension-related deaths and disability adjusted life years (DALYs) for individuals aged ≥60 years was extracted from the Global Burden of Disease (GBD)2021 database for the world, China, and five sociodemographic index (SDI) regions. Age-standardized mortality and DALYs rates for hypertension in the elderly population were calculated, and Joinpoint regression was used to assess trend changes of disease burden, with results reported as average annual percentage change (AAPC). Additionally, subgroup analyses were conducted based on age and sex. The relative impact of aging, population growth, and epidemiological changes on disease burden was analyzed using a three-factor decomposition method. Future projections for the disease burden from 2022 to 2040 were performed using a Bayesian model. From 1990 to 2021, both age-standardized mortality and DALYs rates for hypertension in the elderly population demonstrated a significant downward trend globally and in China (both AAPC values were negative, all Although age-standardized mortality and DALYs rates for hypertension among the elderly in China have shown a downward trend over the past three decades, the absolute burden remains substantial. There is an urgent need for the formulation and implementation of more effective public health policies and clinical interventions to address this critical public health challenge.
2.Treatment of Renal Injury in Wilson Disease Based on Pathogenesis of Latent Toxin in Kidney Collaterals
Ke DIAO ; Wenming YANG ; Xiang LI ; Yue YANG ; Yulong YANG ; Zhihong RAO ; Shuzhen FANG ; Yufeng DING
Chinese Journal of Experimental Traditional Medical Formulae 2025;31(15):132-139
Hepatolenticular degeneration, also known as Wilson disease (WD), is a hereditary disease caused by mutations in the ATP7B gene, leading to copper metabolism disorders. Gene mutations result in impaired synthesis of copper-binding protein, and abnormal excretion of copper through bile leads to pathological deposition of copper in various organs, ultimately causing multi-organ damage. The insidious onset and low specificity of symptoms make it difficult to diagnose this disease. On the basis of existing studies and the theory of latent toxin, this paper proposes that latent toxin in kidney collaterals is the main pathogenesis of renal injury in WD. It is pointed out that health Qi deficiency and latent pathogen are the premises for the occurrence of this disease, and the transformation of latent pathogen into toxin is the ley pathological process. Toxin damaging kidney collaterals is the ultimate result. According to the pathogenesis, this paper proposes the treatment principle of reinforcing healthy Qi and resolving toxin and treatment based on syndrome differentiation. This review provides new ideas for the diagnosis and treatment of renal injury in WD with traditional Chinese medicine.
3.Functional recurrent abdominal pain in adults: A neglected manifestation of migraine
Ke DING ; Guodong XU ; Hebo WANG
Journal of Apoplexy and Nervous Diseases 2025;42(7):600-604
As the third-level diagnosis of migraine, recurrent gastrointestinal disturbance is a group of disorders with recurrent episodic attacks of abdominal pain and/or discomfort and nausea and/or vomiting that may be associated with migraine, and it is a clinical syndrome with the core symptom of abdominal pain, with the presence of clinical and neurobiological associations. This article reviews the similarities of the two diseases from the aspects of epidemiological characteristics, gender distribution tendency, clinical course, auxiliary examination, and treatment response, as well as three potential mechanisms in pathophysiology. This strong association between functional recurrent abdominal pain and migraine suggests that although there is no definitive evidence, adult functional recurrent abdominal pain, or at least its specific subsets, may belong to the spectrum of migraine. In other words, functional recurrent abdominal pain itself without headache may be a “migraine phenomenon”. In the future, it is necessary to conduct more rigorously designed observational studies on the association between the two diseases to clarify such possibility, in order to provide strong supporting evidence for the diagnosis and treatment of patients with functional recurrent abdominal pain and migraine and relieve pain as soon as possible.
4.Correlation between Expression Levels of Tim-3, C-myc and Proportion of T Lymphocyte Subsets and Prognosis in Patients with Acute Lymphoblastic Leukemia.
Yu-Chai ZHONG ; Ke-Ding HU ; Yi-Rong JIANG ; Xiao-Wen HUANG
Journal of Experimental Hematology 2025;33(5):1299-1304
OBJECTIVE:
To analyze the correlation between the expression levels of Tim-3, C-myc and the proportion of T lymphocyte subsets and prognosis in patients with acute lymphoblastic leukemia (ALL).
METHODS:
The research group selected 60 ALL patients admitted to our hospital from December 2019 to December 2021, while the control group selected 55 healthy volunteers who underwent physical examination in our hospital. The expression levels of Tim-3, C-myc mRNA and the proportion of T lymphocyte subsets in the two groups were detected. The mortality rate of ALL patients was calculated, and the correlation between the expression levels of Tim-3, C-myc, and the proportion of T lymphocyte subsets and pathological features and prognosis was analyzed.
RESULTS:
Compared with the control group, the levels of Tim-3, C-myc and CD8+ in the research group were increased, while the levels of CD3+ , CD4+ and CD4+ /CD8+ were decreased (all P < 0.001). The levels of Tim-3, C-myc mRNA, CD3+ , CD4+ , CD8+ , CD4+ /CD8+ were correlated with risk classification and extramedullary infiltration (all P < 0.05). The survival rate of patients with low expression of Tim-3, C-myc, and CD8+ was higher than that of patients with high expression, while the survival rate of patients with high expression of CD3+ , CD4+ , and CD4+ /CD8+ was higher than that of patients with low expression (all P < 0.05). Univariate analysis showed that the deceased patients had higher proportions of extramedullary infiltration and high-risk classification, as well as higher levels of Tim-3, C-myc, and CD8+ , while lower levels of CD3+ , CD4+ , and CD4+ /CD8+ compared with surviving patients (all P < 0.01). Multivariate logistic regression analysis showed that extramedullary invasion, risk classification, Tim-3, C-myc, CD3+ , CD4+ , CD8+ , CD4+ /CD8+ were the main factors affecting the prognosis of ALL patients (all P < 0.05). ROC curve analysis showed that the combination of Tim-3, C-myc, and T lymphocyte subsets had higher sensitivity and accuracy in predicting prognosis of ALL patients compared with the single diagnosis of Tim-3, C-myc, CD3+ , CD4+ , CD8+ , and CD4+ /CD8+ (P < 0.05).
CONCLUSION
ALL patients show higher levels of Tim-3, C-myc mRNA and CD8+ but lower levels of CD3+ , CD4+ and CD4+/CD8+. Moreover, the expression levels of Tim-3, C-myc, CD3+ , CD4+ , CD8+ and CD4+/CD8+ are correlated with extramedullary invasion, high-risk classification and prognosis.
Humans
;
Hepatitis A Virus Cellular Receptor 2/metabolism*
;
Prognosis
;
Proto-Oncogene Proteins c-myc/metabolism*
;
Precursor Cell Lymphoblastic Leukemia-Lymphoma/diagnosis*
;
T-Lymphocyte Subsets
;
Male
;
Female
;
Adult
;
Middle Aged
;
Adolescent
;
RNA, Messenger
5.Integrated Medicine Treatment of Rare Bone Marrow Tuberculosis in Systemic Lupus Erythematosus and Potentiating and Detoxifying Effects of Chinese Medicine: A Case Report.
Wu CHEN ; Lin HUANG ; Wei-Man SHI ; Ke MA ; Cheng-Ping WEN ; Qiao-Ding DAI
Chinese journal of integrative medicine 2025;31(2):153-156
6.Regulation of histidine metabolism by Lactobacillus Reuteri mediates the pathogenesis and treatment of ischemic stroke.
Kangrui HU ; Zhihao ZHOU ; Haofeng LI ; Jijun XIAO ; Yun SHEN ; Ke DING ; Tingting ZHANG ; Guangji WANG ; Haiping HAO ; Yan LIANG
Acta Pharmaceutica Sinica B 2025;15(1):239-255
Increasing evidence has underscored the significance of post-stroke alterations along gut-brain axis, while its role in pathogenesis and treatment of ischemic stroke (IS) remains largely unexplored. This study aimed to elucidate the therapeutic effects and action targets of Panax notoginseng saponins (PNS) on IS and explore a novel pathogenesis and treatment strategy of IS via profiling the microbial community and metabolic characteristics along gut-brain axis. Our findings revealed for the first time that the therapeutic effect of PNS on IS was microbiota-dependent. Ischemia/reperfusion (I/R) modeling significantly down-regulated Lactobacilli in rats, and PNS markedly recovered Lactobacilli, particularly Lactobacillus reuteri (L.Reu). Metabolomics showed a significant reduction in serum histidine (HIS) in clinical obsolete IS patients and rehabilitation period I/R rats. Meanwhile, the L.Reu colonization in I/R rats exhibited significant neuroprotective activity and greatly increased HIS in serum, gut microbiota, and brain. Moreover, exogenous HIS demonstrated indirect neuroprotective effects through metabolizing to histamine. Notably, vagus nerve severance in I/R rats was performed to investigate HIS's neuroprotective mechanism. The results innovatively revealed that PNS could promote HIS synthesis in gut by enhancing L.Reu proportion, thereby increasing intracerebral HIS through peripheral pathway. Consequently, our data provided novel insights into HIS metabolism mediated by L.Reu in the pathogenesis and treatment of IS.
7.Shenqi Buzhong Formula ameliorates mitochondrial dysfunction in a rat model of chronic obstructive pulmonary disease by activating the AMPK/SIRT1/PGC-1α pathway.
Lu ZHANG ; Huanzhang DING ; Haoran XU ; Ke CHEN ; Bowen XU ; Qinjun YANG ; Di WU ; Jiabing TONG ; Zegeng LI
Journal of Southern Medical University 2025;45(5):969-976
OBJECTIVES:
To explore the mechanism of Shenqi Buzhong (SQBZ) Formula for alleviating mitochondrial dysfunction in a rat model of chronic obstructive pulmonary disease (COPD) in light of the AMPK/SIRT1/PGC-1α pathway.
METHODS:
Fifty male SD rat models of COPD, established by intratracheal lipopolysaccharide (LPS) instillation, exposure to cigarette smoke, and gavage of Senna leaf infusion, were randomized into 5 groups (n=10) for treatment with saline (model group), SQBZ Formula at low, moderate and high doses (3.08, 6.16 and 12.32 g/kg, respectively), or aminophylline (0.024 g/kg) by gavage for 4 weeks, with another 10 untreated rats as the control group. Pulmonary function of the rats were tested, and pathologies and ultrastructural changes of the lung tissues were examined using HE staining and transmission electron microscopy. The levels of SOD, ATP, MDA, and mitochondrial membrane potential in the lungs were detected using WST-1, colorimetric assay, TBA, and JC-1 methods. Flow cytometry was used to analyze ROS level in the lung tissues, and the protein expression levels of P-AMPKα, AMPKα, SIRTI, and PGC-1α were detected using Western blotting.
RESULTS:
The rat models of COPD showed significantly decreased lung function, severe histopathological injuries of the lungs, decreased pulmonary levels of SOD activity, ATP and mitochondrial membrane potential, increased levels of MDA and ROS, and decreased pulmonary expressions of P-AMPKα, SIRTI, and PGC-1α proteins. All these changes were significantly alleviated by treatment with SQBZ Formula and aminophylline, and the efficacy was comparable between high-dose SQBZ Formula group and aminophylline group.
CONCLUSIONS
SQBZ Formula ameliorates mitochondrial dysfunction in COPD rats possibly by activating the AMPK/SIRT1/PGC-1α pathway.
Animals
;
Pulmonary Disease, Chronic Obstructive/drug therapy*
;
Drugs, Chinese Herbal/therapeutic use*
;
Sirtuin 1/metabolism*
;
Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha
;
Rats, Sprague-Dawley
;
Male
;
Rats
;
AMP-Activated Protein Kinases/metabolism*
;
Mitochondria/metabolism*
;
Disease Models, Animal
;
Signal Transduction/drug effects*
8.Changes in metabolic markers and the risk of new-onset metabolic associated fatty liver disease in previously untreated patients with HIV infection after lamivudine/efavirenz/tenofovir disoproxil fumarate treatment
Ding ZHU ; Ruixue LI ; Hengning KE
Journal of Clinical Hepatology 2025;41(11):2294-2299
ObjectiveTo investigate the impact of metabolic associated fatty liver disease (MAFLD) on metabolic markers in patients with HIV infection, and to assess the risk of new-onset MAFLD in previously untreated HIV patients. MethodsA total of 161 HIV patients who attended the outpatient service of Zhongnan Hospital of Wuhan University from April 2020 to December 2021 were enrolled, and they were treated with the lamivudine/efavirenz/tenofovir disoproxil fumarate (3TC/EFV/TDF) regimen and were followed up for more than 36 months. According to the presence or absence of MAFLD, they were divided into MAFLD group with 42 patients and non-MAFLD group with 119 patients, and metabolic markers were compared between the two groups before and after treatment. The independent-samples t test was used for comparison of normally distributed continuous data between two groups, and the paired t-test was used for comparison within each group before and after treatment; the Mann-Whitney U test was used for comparison of non-normally distributed continuous data between two groups, and the Wilcoxon signed-rank test was used for comparison within each group before and after treatment; the chi-square test was used for comparison of categorical data between groups. Hepatic steatosis index (HIS) and Zhejiang University (ZJU) index were used to assess the risk of new-onset MAFLD after antiretroviral therapy. ResultsAfter 36 months of 3TC/EFV/TDF treatment, the MAFLD group had significant increases in body mass index (BMI) [24.8 (23.2 — 25.9) kg/m2 vs 25.3 (22.8 — 27.7) kg/m2, Z=-2.540, P=0.011], total cholesterol (TC) (4.0±0.6 mmol/L vs 4.3±0.6 mmol/L, t=-2.388, P=0.022), and high-density lipoprotein cholesterol (HDL-C) [0.9 (0.8 — 1.1) mmol/L vs 1.1 (0.9 — 1.2) mmol/L, Z=-2.858, P=0.004] and a significant reduction in serum uric acid (462.1±101.6 μmol/L vs 383.3±85.2 μmol/L, t=4.361, P<0.001). There was a significant difference in BMI between the MAFLD group and the non-MAFLD group after 3TC/EFV/TDF treatment [25.3 (22.8 — 27.7) kg/m2 vs 21.6 (19.9 — 23.4) kg/m2, Z=-5.462, P<0.001], while there were no significant differences between the two groups in serum uric acid, TC, triglyceride, HDL-C, low-density lipoprotein cholesterol, lipoprotein a, and CD4+ T cell count (all P >0.05). Furthermore, for the patients in the non-MAFLD group after treatment, there was a significant increase in the proportion of patients at a high risk of MAFLD based on HSI and ZJU indices (χ²=10.829 and 5.658, P=0.001 and 0.017). ConclusionAfter 36 months of 3TC/EFV/TDF treatment, there are increases in blood lipid levels in HIV patients with MAFLD, and there is an increase in the risk of new-onset MAFLD in HIV patients without MAFLD.
9.Dryness of Atractylodis Rhizoma: A Review
Ding YAO ; Chang KE ; Songyang YU ; Kang XU ; Yanju LIU ; Linghang QU
Chinese Journal of Experimental Traditional Medical Formulae 2024;30(19):292-298
Dryness is an important concept in the theory of traditional Chinese medicine, which is closely related to the transformation of the body, etiology and pathogenesis. As one of the medicinal properties of Chinese materia medica, there are various types of Chinese materia medica with dryness. Atractylodis Rhizoma(AR) is a representative medicine with warm and dry properties, which has the function of drying dampness and strengthening the spleen. Due to its strong dryness, it can cause certain adverse reactions. In clinical practice, stir-fried AR with bran is often used as medicine. The dryness of AR is closely related to its efficacy, but the underlying mechanism of the relationship between dryness and efficacy is still unclear. At present, the research on dryness Chinese materia medica has been increasing year by year, but there are still problems such as insufficient systematic research, insufficient in-depth research and lack of research on the mechanism of dryness effect, which limit the breakthrough of the theory of processing for slowing down dryness, and hinder the precise application of dryness Chinese materia medica in clinical practice. Therefore, this article comprehensively reviewed the differences in dryness characterization indicators of different Chinese materia medica by searching domestic and foreign literature, focusing on the relevant research on dryness of AR. A systematic summary and induction were made from the characterization indicators, research techniques of dryness markers, the influence of processing on dryness of AR, and the application mining of dryness of AR. The results showed that the dryness characteristics of AR mainly included the upregulation of macroscopic indicators such as water intake, urine output and whole blood viscosity, as well as energy metabolism indicators, the downregulation of water metabolism indicators, and pathological changes such as submandibular gland acinar atrophy. Based on the changes of dryness and component content of AR after processing, it is determined that the main dryness components of AR may be volatile components such as β-eudesmol and atractylon. Due to its dryness, AR is mainly used to treat diseases such as spleen deficiency, rheumatism and edema. However, the current understanding of the correlation between dryness and efficacy of AR is still insufficient, and there are still many bottlenecks in understanding and explaining its dryness. In the future, systematic evaluation and characterization should be carried out to find the common mechanism of AR exerting dryness and efficacy, providing reference for the rational clinical use.
10.Association between gut microbiota and polycystic ovary syndrome: a Mendelian randomization study
CHEN Ying ; LIU Ke ; LIU Bin ; SUN Xiaohui ; HE Zhixing ; MAO Yingying ; YE Ding
Journal of Preventive Medicine 2024;36(9):801-805
Objective:
To investigate the causal relationship between gut microbiota and polycystic ovary syndrome (PCOS) using a Mendelian randomization (MR) study, so as to provide insights into the pathogenesis of PCOS and the formulation of prevention and treatment strategies.
Methods:
The genetic data on gut microbiota was derived from a meta-analysis of genome-wide association studies (GWAS) involving 18 340 participants. The genetic data on PCOS was sourced from two GWAS meta-analyses in European populations, serving as the discovery set and the validation set, respectively. A two-sample MR analysis was conducted using the discovery set, with the inverse variance weighted (IVW) method as the primary approach. Sensitivity analyses employed the weighted median method, MR-Egger regression, and the MR-PRESSO test. The validation set was utilized for verification, and a meta-analysis was performed to combine the results from the two datasets.
Results:
Forward MR analysis results showed that nine types of gut microbiota were statistically associated with PCOS (all P<0.05). Specifically, the association of family Streptococcaceae (OR=1.442, 95%CI: 1.097-1.895), genus Actinomyces (OR=1.359, 95%CI: 1.036-1.784), genus Ruminococcaceae UCG 011 (OR=0.755, 95%CI: 0.619-0.921), genus Sellimonas (OR=0.766, 95%CI: 0.657-0.893) and genus Streptococcus with PCOS (OR=1.496, 95%CI: 1.136-1.972) remained consistent in the sensitivity analysis. Reverse MR analysis showed no evidence for the causal association between PCOS and the aforementioned five types of gut microbiota (all P>0.05). The MR analysis results of the validation set showed that there was no statistical association between the aforementioned five types of gut microbiota and PCOS (all P>0.05). However, the associations remained significant for genus Actinomyces (OR=1.226,95%CI:1.010-1.503) and genus Streptococcus (OR=1.266,95%CI:1.042-1.452) in the meta-analysis (both P<0.05).
Conclusion
This study provides the evidence that genus Actinomyces and genus Streptococcus are causally associated with PCOS.


Result Analysis
Print
Save
E-mail